ONE-WAYOngoing theme · still written in the latest filings
Risk of Responding to Changes in Pharmaceutical Regulations and Government Policies in the CRO Business
Risk that changes in pharmaceutical regulations and government policies applicable to the CRO business, including the Pharmaceuticals and Medical Devices Act, GCP, GPSP and GVP, could result in the discontinuation of contracted work, the need to secure additional personnel and increased capital investment requirements.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.
PeriodFY2020 →Still being written about.
Directionhurts0 helps · 2 hurts · 0 flat